Natural Product: NPC476620

Natural Product IDNPC476620
Common Name
?
The InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
[(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxoxanthen-2-yl)oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
IUPAC Name [(2R,3S,4S,5R,6S)-3,4,5-trihydroxy-6-(1,3,6,7-tetrahydroxy-9-oxoxanthen-2-yl)oxyoxan-2-yl]methyl (E)-3-(4-hydroxyphenyl)prop-2-enoate
Synonyms
Synthetic Gene Cluster n.a.
ChEMBL Identifier n.a.
PubChem CID 45481963
Chemical Classification
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000002] Organoheterocyclic compounds
      • [CHEMONTID:0000123] Benzopyrans
        • [CHEMONTID:0003410] 1-benzopyrans
          • [CHEMONTID:0002817] Dibenzopyrans
            • [CHEMONTID:0000200] Xanthenes
              • [CHEMONTID:0000204] Xanthones

The Chemical Classification was calculated by Classyfire, a software for chemical taxonomy calculation. Reference: DOI:10.1186/s13321-016-0174-y.

  Chemical Representations

Standard InCHIKey LKAUZCQGGQBXJB-KSSKDEGSSA-N
Standard InCHI InChI=1S/C28H24O14/c29-12-4-1-11(2-5-12)3-6-20(33)39-10-19-23(35)25(37)26(38)28(41-19)42-27-16(32)9-18-21(24(27)36)22(34)13-7-14(30)15(31)8-17(13)40-18/h1-9,19,23,25-26,28-32,35-38H,10H2/b6-3+/t19-,23-,25+,26-,28+/m1/s1
SMILES C1=CC(=CC=C1/C=C/C(=O)OC[C@@H]2[C@H]([C@@H]([C@H]([C@@H](O2)OC3=C(C4=C(C=C3O)OC5=CC(=C(C=C5C4=O)O)O)O)O)O)O)O

  Calculated Properties

Physi-Chem Properties

Molecular Weight:   584.12 Volume:   541.487
?
Van der Waals volume.
Dense:   1.079 LogP:   1.187
?
The logarithm of the n-octanol/water distribution coefficients.
logD7.4:   1.164
?
The logarithm of the n-octanol/water distribution coefficient at pH=7.4.
LogS:   -4.178
?
The logarithm of aqueous solubility value.
Rotatable Bonds:   7.0 Rigid Bonds:   31.0
TPSA:   236.81
?
Topological Polar Surface Area.
H-Bond Acceptor:   14.0
H-Bond Donor:   8.0 Rings:   5.0
Heavy Atoms:   14.0

MedChem Properties

QED Drug-Likeness Score:   0.068 GASA:   1.0
?
GASA represents the probability of being difficult to synthesize, ranging from 0 to 1.
Synthetic Accessibility Score:   4.289 Fsp3:   0.214
MCE-18:   108.706
?
MCE-18 stands for medicinal chemistry evolution.MCE-18≥45 is considered a suitable value.
Lipinski Rule-of-5:   Accepted
Pfizer Rule:   Rejected GSK Rule:   Accepted
Golden Triangle Rule:   Accepted BMS Rule:   1
Chelating Alert:   1 PAINS Alert:   1
Colloidal aggregators:   0.757 Fluc inhibitor:   0.579
?
The fluc inhibitor value is the probability of being fLuc inhibitors, within the range of 0 to 1.
Blue fluorescence:   0.958
?
The blue fluorescence value is the probability of being blue fluorescence, within the range of 0 to 1
Green fluorescence:   0.986
?
The green fluorescence value is the probability of being green fluorescence, within the range of 0 to 1
Reactive compounds:   0.139 Promiscuous compounds:   0.81

ADMET Properties (ADMETlab3.0)

ADMET: Absorption

Caco-2 Permeability:   -6.485 MDCK Permeability:   -5.041
Pgp-inhibitor:   0.001 Pgp-substrate:   0.359
PAMPA:   0.987
?
The experimental data for Peff was logarithmically transformed (logPeff). Molecules with log Peff values below 2.0 were classified as low-permeability (Category 0), while those with log Peff values exceeding 2.5 were classified as high-permeability (Category 1).
Human Intestinal Absorption (HIA):   0.012
20% Bioavailability (F20%):   0.969 30% Bioavailability (F30%):   0.998
50% Bioavailability (F50%):   1.0

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):   0.0 MRP1:   0.018
Plasma Protein Binding (PPB):   85.385% Volume Distribution (VD):   -0.046
Fu: 12.198%
?
The fraction unbound in plasms.
OATP1B1 inhibitor:   0.983
OATP1B3 inhibitor:   0.997 BCRP inhibitor:   0.494
BSEP inhibitor:   0.824

ADMET: Metabolism

CYP1A2-inhibitor:   0.002 CYP1A2-substrate:   0.002
CYP2C19-inhibitor:   0.0 CYP2C19-substrate:   0.12
CYP2C9-inhibitor:   0.0 CYP2C9-substrate:   0.0
CYP2D6-inhibitor:   0.001 CYP2D6-substrate:   0.399
CYP3A4-inhibitor:   0.0 CYP3A4-substrate:   0.971
CYP2B6-substrate:   0.0 CYP2C8-inhibitor:   1.0
HLM stability:   0.46
?
Human liver microsomal (HLM) stability. Category 0: stable+ (HLM > 30 min); Category 1: unstable- (HLM ≤ 30 min). The output value is the probability of human liver microsomal instability, where a value closer to 1 indicates a higher likelihood of instability.

ADMET: Excretion

Clearance (CL):  3.241 Half-life (T1/2):  3.02

ADMET: Toxicity

hERG Blockers:  0.047 hERG Blockers (10um):  0.581
Human Hepatotoxicity (H-HT):  0.442 Drug-induced Liver Injury (DILI):  0.979
AMES Toxicity:  0.856 Rat Oral Acute Toxicity:  0.133
Maximum Recommended Daily Dose:  0.776 Skin Sensitization:  0.998
Carcinogencity:  0.208 Eye Corrosion:  0.0
Eye Irritation:  0.922 Respiratory Toxicity:  0.058
Drug-induced Neurotoxicity:  0.002 Ototoxicity:  0.623
Hematotoxicity:  0.012 Drug-induced Nephrotoxicity:  0.115
Genotoxicity:  0.985 RPMI-8226 Immunitoxicity:  0.054
A549 Cytotoxicity:  0.862 Hek293 Cytotoxicity:  0.745
BCF:   0.688
?
Bioconcentration factors are used for considering secondary poisoning potential and assessing risks to human health via the food chain. The unit is -log10[(mg/L)/(1000*MW)].
IGC50:   3.553
?
48 hour Tetrahymena pyriformis IGC50. The unit of IGC50 is -log10[(mg/L)/(1000*MW)].
LC50DM:   4.703
?
48 hour Daphnia magna LC50. The unit of LC50DM is -log10[(mg/L)/(1000*MW)].
LC50FM:   4.319
?
96 hour fathead minnow LC50. The unit of LC50FM is -log10[(mg/L)/(1000*MW)].

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO33596 Arrabidaea patellifera Species Bignoniaceae Eukaryota leaves Valle de Antn, los Llanitos, Panama 2003-APR PMID[18950229]

Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



  NP Quantity Composition/Concentration

Organism ID Organism Name Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].



 Biological Activity

Molecular-level activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference

In vitro activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT6 Organism Plasmodium falciparum Plasmodium falciparum IC50 > 38200 nM PMID[18950229]
NPT1 Others Radical scavenging activity n.a. Ratio = 0.23 n.a. PMID[18950229]
NPT2 Others Unspecified n.a. EC50 = 1480 nM PMID[18950229]

In vivo activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference





 Experimental ADME

Experiment Model Experiment Tissue ADME Type ADME Relation ADME Value ADME Unit Reference





 Experimental Toxicity

Quantitative toxicity

Experiment Model Experiment Organism Toxicity Type Toxicity Relation Toxicity Value Toxicity Unit Reference

Common Abbreviations:
LC: Lethal Concentration; LD: Lethal Dose; LT:Lethal Time; NOAEL: No-observed-adverse-effect Level; BMDL: Benchmark Dose Lower Confidence Limit; BMD: Benchmark Dose; BMC:Benchmark Concentration; LOAEL: Lowest Observed Adverse Effect Level; RfD:Reference Dose; RfC:Reference Concentration; MRL: Minimal Risk Level; MEG: Maximum Exposure Guideline; PAC: Protective Action Criteria

Categorical toxicity labels

Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption
Hepatotoxicity Carcinogenicity Mutagenicity Cardiotoxicity Respiratory Toxicity Eye Irritation Endocrine Disruption

Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP toxicity records from domain-specific databases. These databases include:
ToxValDB: a curated database that compiles quantitative toxicity values for chemicals from diverse public sources to support toxicological research and risk assessment.
TOXRIC: a comprehensive, free-to-access, online database providing toxicological/feature data. The toxicity labels are retrieved from this database. [PMID: 36400569]


  Chemically structural similarity

Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes approximately 50,000 NPs with experimentally-derived bioactivity available in NPASS)

Similarity is measured using the Tanimoto coefficient (Tc) , which compares the binary fingerprints of two molecules. Tc is calculated as the intersection divided by the union of '1' bits in the fingerprints, ranging from 0 to 1, with 1 indicating highest similarity.

●  The left chart: Distribution of similarity level between NPC476620 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.5 or Top200).

Similarity Score Similarity Level Natural Product ID
0.6737 Remote Similarity NPC476619
0.6465 Remote Similarity NPC36138
0.6061 Remote Similarity NPC476622
0.596 Remote Similarity NPC476621
0.5922 Remote Similarity NPC223426
0.5909 Remote Similarity NPC291153
0.5905 Remote Similarity NPC470416
0.5882 Remote Similarity NPC80068
0.5882 Remote Similarity NPC85751
0.5882 Remote Similarity NPC19240
0.5882 Remote Similarity NPC477629
0.5784 Remote Similarity NPC270675
0.5784 Remote Similarity NPC195685
0.5714 Remote Similarity NPC476618
0.5699 Remote Similarity NPC10205
0.566 Remote Similarity NPC599948
0.5579 Remote Similarity NPC204937
0.5566 Remote Similarity NPC214621
0.5566 Remote Similarity NPC34267
0.5556 Remote Similarity NPC477895
0.5505 Remote Similarity NPC217520
0.5472 Remote Similarity NPC472994
0.5421 Remote Similarity NPC81042
0.5421 Remote Similarity NPC603856
0.5326 Remote Similarity NPC34287
0.5326 Remote Similarity NPC157898
0.5273 Remote Similarity NPC480796
0.5273 Remote Similarity NPC472993
0.5253 Remote Similarity NPC476870
0.5204 Remote Similarity NPC476869
0.5204 Remote Similarity NPC476866
0.5133 Remote Similarity NPC139571
0.5096 Remote Similarity NPC271848
0.5052 Remote Similarity NPC291296

Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC476620 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.5 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
NPD

Bioactivity similarity

  Bioactivity similarity

Similar Natural Products in NPASS

Similarity level is defined by Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.
Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data